Radiofrequency Ablation Devices Market for Pain Management, By Product (Equipment, Reusables (Probes, Electrodes), Disposables (Cannulas, Needles, RF- Single Use Probe, RF- Single Use Electrodes)), By End User (Hospitals, Ambulatory Surgical Centers, Clin

Radiofrequency Ablation Devices Market for Pain Management, By Product (Equipment, Reusables (Probes, Electrodes), Disposables (Cannulas, Needles, RF- Single Use Probe, RF- Single Use Electrodes)), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Ablation has gained immense popularity all over the world as it offers minimally invasive solutions for the removal of tissues or tumors with bearable pain, and a lesser recovery period compared to open surgical procedures. Demand for ablation devices is expected to increase owing to increasing incidence of chronic diseases, mainly tumorigenic cancer and other cardiovascular disorders, across the globe. Chronic diseases are the major cause of mortality which resulted in over 38 million deaths worldwide in 2015, according to the World Health Organization (WHO).
Restraints of the Global Radiofrequency Ablation Devices Market for Pain Management
Major factors hampering the growth of the radiofrequency ablation devices market for pain management during the forecast period constitutes of high costs, and low awareness of ablation technique.
Key features of the study:
This report provides in-depth analysis of the global radiofrequency ablation devices market for pain management and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global radiofrequency ablation devices market for pain management based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Accuray, Inc., Avanos Medical, Inc., Boston Scientific Corporation, Biosense Webster, Inc., Cosman Medical, Inc., Diros Technology, Inc., Kimberly-Clark Corporation, NeuroTherm, Inc., St. Jude Medical, Inc., and Stryker Corporation.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global radiofrequency ablation devices market for pain management report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Radiofrequency Ablation Devices Market for Pain Management, By Product:
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
Global Radiofrequency Ablation Devices Market for Pain Management, By End User:
Hospitals
Ambulatory Surgical Centers
Clinics
Global Radiofrequency Ablation Devices Market for Pain Management, By Geography:
North America
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country:
U.S.
Canada
Europe
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product
Equipment
Reusables
Probes
Electrodes
Disposables
Cannulas
Needles
RF- Single Use Probe
RF- Single Use Electrodes
By End User
Hospitals
Ambulatory Surgical Centers
Clinics
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Accuray, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Avanos Medical, Inc.
Boston Scientific Corporation
Biosense Webster, Inc.
Cosman Medical, Inc.
Diros Technology, Inc.
Kimberly-Clark Corporation
NeuroTherm, Inc.
St. Jude Medical, Inc.
Stryker Corporation
“*” marked represents similar segmentation in other categories in the respective section.